Prescribing of tamoxifen by practices in NHS CORNWALL AND THE ISLES OF SCILLY
Why it matters: Alongside its use as a cancer treatment, in 2013 NICE recommended that tamoxifen should also be prescribed for chemoprevention of breast cancer for pre-menopausal women at increased risk. Improving the use of preventative therapies was also reiterated in England's Cancer Strategy for 2015-2020. This measure accompanies our paper investigating the national response to these guidelines, published in the British Journal of Cancer.
Description: Number of Average Daily Quantities (ADQs) for tamoxifen (20mg/day) per 1000 female population aged 35-74.
Explore:
Tagged as: NICE, Mentioned in Papers (or browse all measures for this Sub-ICB Location)
Practices are ordered by mean percentile over the past six months, with the worst-performing at the top. Each chart shows the results for the individual practice, plus deciles across all practices in the NHS in England.
View measure as combined total for this Sub-ICB Location →
Fetching data...